| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI57925 |
| P8608 | Fatcat ID | release_2msv35cd3zdcfgezomksoukelq |
| P932 | PMC publication ID | 3223926 |
| P698 | PubMed publication ID | 21865642 |
| P50 | author | Michael S Magee | Q45277387 |
| Adam E. Snook | Q45277404 | ||
| Scott A. Waldman | Q54290173 | ||
| P2093 | author name string | Peng Li | |
| Terry Hyslop | |||
| Stephanie Schulz | |||
| Jieru E Lin | |||
| Glen Marszalowicz | |||
| Michael A Valentino | |||
| Gilbert W Kim | |||
| P2860 | cites work | A role for glucagon-like peptide-1 in the central regulation of feeding | Q24314317 |
| Guanylin: an endogenous activator of intestinal guanylate cyclase | Q24563294 | ||
| Recent advances in understanding leptin signaling and leptin resistance | Q24658188 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Critical role for peptide YY in protein-mediated satiation and body-weight regulation | Q28261574 | ||
| Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load | Q28504773 | ||
| Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity | Q28509565 | ||
| Cholecystokinin-A receptors are involved in food intake suppression in rats after intake of all fats and carbohydrates tested | Q28569760 | ||
| Guanylyl cyclase is a heat-stable enterotoxin receptor | Q28581707 | ||
| Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice | Q28591312 | ||
| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 | ||
| The world health report 2002 - reducing risks, promoting healthy life | Q29615448 | ||
| Weight-reducing effects of the plasma protein encoded by the obese gene | Q29617934 | ||
| Gene expression profiles in normal and cancer cells | Q29619943 | ||
| Central and peripheral molecular targets for antiobesity pharmacotherapy | Q30388865 | ||
| Escherichia coli heat-stable toxin receptors in human colonic tumors. | Q54622815 | ||
| Intestinal lipid absorption is not affected in CD36 deficient mice | Q57232709 | ||
| Identification of 10-kDa proguanylin as a major guanylin molecule in human intestine and plasma and its increase in renal insufficiency | Q72384516 | ||
| Guanosine 3',5'-cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine | Q73047903 | ||
| Expression of guanylin is downregulated in mouse and human intestinal adenomas | Q73938431 | ||
| Guanylin mRNA expression in human intestine and colorectal adenocarcinoma | Q74165301 | ||
| Gene expression in colorectal cancer | Q74558243 | ||
| Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats | Q74755419 | ||
| Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity | Q30490467 | ||
| Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety | Q30547647 | ||
| Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics | Q33208551 | ||
| Natural variation in food acquisition mediated via a Drosophila cGMP-dependent protein kinase | Q33390170 | ||
| Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase | Q34321734 | ||
| Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity | Q34423605 | ||
| The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor) | Q35760474 | ||
| The gut and energy balance: visceral allies in the obesity wars | Q36080128 | ||
| Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. | Q36202841 | ||
| Cellular effects of guanylin and uroguanylin | Q36355167 | ||
| Overweight and obesity: prevalence, consequences, and causes of a growing public health problem | Q36450375 | ||
| The paracrine hormone hypothesis of colorectal cancer. | Q36905454 | ||
| Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules | Q36908897 | ||
| Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide | Q36908915 | ||
| Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 | Q36942662 | ||
| Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues | Q37053969 | ||
| Differential susceptibility to obesity between male, female and ovariectomized female mice | Q37116124 | ||
| Effect of leptin deficiency on metabolic rate in ob/ob mice | Q38327333 | ||
| The guanylin/STa receptor is expressed in crypts and apical epithelium throughout the mouse intestine | Q38353833 | ||
| The development of obesity in genetically diabetic-obese (db/db) mice pair-fed with lean siblings. The importance of thermoregulatory thermogenesis | Q38356840 | ||
| The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. | Q39802240 | ||
| Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. | Q40951409 | ||
| Increased lipid absorption and transport in the small intestine of zucker obese rats | Q42059836 | ||
| Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases | Q42624644 | ||
| Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome | Q43352181 | ||
| Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor | Q44692943 | ||
| Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C. | Q46654154 | ||
| Peripheral oxyntomodulin reduces food intake and body weight gain in rats. | Q47426818 | ||
| Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure | Q47945051 | ||
| Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. | Q48142709 | ||
| Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. | Q52065686 | ||
| The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response. | Q53613664 | ||
| Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. | Q54564603 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3578-3588 | |
| P577 | publication date | 2011-08-25 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | A uroguanylin-GUCY2C endocrine axis regulates feeding in mice | |
| P478 | volume | 121 |
| Q47587497 | A Pilot Study Measuring The Novel Satiety Hormone, Pro-Uroguanylin, In Adolescents With And Without Obesity |
| Q36796083 | A role for natriuretic peptides in the central control of energy balance? |
| Q42219451 | ASI regulates satiety quiescence in C. elegans |
| Q30354242 | Antiobesity pharmacotherapy: new drugs and emerging targets |
| Q36530375 | Appetite Control: worm's-eye-view. |
| Q91988489 | Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation |
| Q28828838 | Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity |
| Q37092650 | Cellular localization of guanylin and uroguanylin mRNAs in human and rat duodenal and colonic mucosa |
| Q91012100 | Characterisation of proguanylin expressing cells in the intestine - evidence for constitutive luminal secretion |
| Q59126114 | Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty |
| Q38223422 | Current understanding of guanylin peptides actions. |
| Q36918732 | Dietary salt regulates uroguanylin expression and signaling activity in the kidney, but not in the intestine |
| Q36086880 | Dietary whey protein lessens several risk factors for metabolic diseases: a review |
| Q34393417 | Effect of guanylate cyclase-C activity on energy and glucose homeostasis |
| Q27025808 | From Escherichia coli heat-stable enterotoxin to mammalian endogenous guanylin hormones |
| Q41925319 | GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome |
| Q37146309 | GUCY2C ligand replacement to prevent colorectal cancer. |
| Q34619403 | GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer |
| Q41625041 | GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity |
| Q37950928 | GUCY2C-targeted cancer immunotherapy: past, present and future. |
| Q36741685 | GUCY2C: at the intersection of obesity and cancer |
| Q82502625 | Gastrointestinal hormones: uroguanylin-a new gut-derived weapon against obesity? |
| Q90172850 | Genomic and epigenomic mapping of leptin-responsive neuronal populations involved in body weight regulation |
| Q39120155 | Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer |
| Q37296767 | Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis |
| Q37284644 | Guanylin and uroguanylin are produced by mouse intestinal epithelial cells of columnar and secretory lineage |
| Q47438005 | Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes |
| Q38850722 | Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer |
| Q39430494 | Guanylyl cyclase C and guanylin reduce fat droplet accumulation in cattle mesenteric adipose tissue |
| Q28074181 | Guanylyl cyclase C signaling axis and colon cancer prevention |
| Q47723017 | Guanylyl cyclase-G is an alarm pheromone receptor in mice |
| Q35543592 | Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain |
| Q35667150 | Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy |
| Q27021781 | Gut-central nervous system axis is a target for nutritional therapies |
| Q58924836 | Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases |
| Q64124647 | Immunizations with enterotoxigenic heat-stable toxin conjugates engender toxin-neutralizing antibodies in mice that also cross-react with guanylin and uroguanylin |
| Q47657556 | Immunohistochemical Staining for Uroguanylin, a Satiety Hormone, Is Decreased in Intestinal Tissue Specimens From Female Adolescents With Obesity |
| Q55234669 | Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function. |
| Q30815469 | Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins |
| Q43736109 | Intestinal and renal guanylin peptides system in hypertensive obese mice |
| Q26865399 | Mechanisms of Weight Regain following Weight Loss |
| Q38794203 | Molecular Physiology of Membrane Guanylyl Cyclase Receptors |
| Q38288274 | Natriuretic hormones in brain function |
| Q30429816 | New advances in models and strategies for developing anti-obesity drugs |
| Q38178827 | Pendrin, a novel transcriptional target of the uroguanylin system |
| Q38061797 | Peripheral signalling involved in energy homeostasis control |
| Q36790193 | Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis |
| Q39142095 | Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope |
| Q40274361 | Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells |
| Q52589288 | Selective inhibition of intestinal guanosine 3',5'-cyclic monophosphate signaling by small-molecule protein kinase inhibitors. |
| Q41516500 | Simple MD-based model for oxidative folding of peptides and proteins |
| Q39220487 | Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36. |
| Q64097244 | Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients |
| Q38123372 | The endocrinology of food intake |
| Q38028211 | The multiple and enigmatic roles of guanylyl cyclase C in intestinal homeostasis |
| Q36854953 | The receptor guanylyl cyclase type D (GC-D) ligand uroguanylin promotes the acquisition of food preferences in mice |
| Q34293073 | The uroguanylin system and human disease |
| Q92758264 | Uroguanylin Improves Leptin Responsiveness in Diet-Induced Obese Mice |
| Q38300625 | Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner. |
| Q35187154 | Uroguanylin: how the gut got another satiety hormone |
| Q38220091 | cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications |